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Abstract
Introduction: The aim of this study was to investigate the current status of sonographic characteristics of thyroid nodules in Isfahan,
a previously iodine deficient area in central Iran.
Material and methods: In a cross-sectional study conducted in 2006, 2523 adult people (age > 20 years) were selected by a multistage
clustering sampling method. Of these people, 263 volunteered persons were underwent sonographic evaluation. Thyroid examination
was done by two expert sonographers. Serum T3, T4, T3RU, TSH, TPO Ab and Tg Ab, and urinary iodine were measured.
Results: Forty-six per cent of the 263 people were women. Their mean age was 35.5 years with a range of 20-64 years. Median urinary
iodine was 19.4 µg/dL. The prevalence of thyroid nodules on sonography was 22.4% in the whole group; 30% in women and 16.3% in men
(OR = 2.2, P = 0.01). The prevalence of thyroid nodules increased with age (P = 0.006). The prevalence of thyroid nodules was higher in
hypothyroid people than in euthyroid people (35.1% v. 20.5%, OR = 2.1, P = 0.04). Neither urinary iodine nor autoantibody concentra-
tions correlated with the prevalence of thyroid nodules in sonography.
Conclusions: The prevalence of thyroid nodule by sonography is still high despite relatively normal urinary iodine in this population.
(Pol J Endocrinol 2010; 61 (2): 188–191)
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Streszczenie
Wstęp: Celem badania była ocena cech sonograficznych zmian ogniskowych tarczycy u mieszkańców Isfahanu, obszaru w cenralnym
Iranie, który wcześniej charakteryzował się niedoborem jodu.
Materiał i metody: W przekrojowym badaniu przeprowadzonym w 2006 roku wybrano próbę liczącą 2523 dorosłych osób (wiek > 20 lat)
metodą wielostopniowego losowania grupowego. Spośród tej grupy, 263 ochotników poddano badaniom sonograficznym. Badanie tar-
czycy przeprowadzili doświadczeni specjaliści w zakresie ultrasonografii. Ponadto oznaczono stężenia T3, T4, T3RU, TSH, TPO Ab
i Tg Ab w surowicy oraz wydalanie jodu z moczem.
Wyniki: Kobiety stanowiły 46% grupy poddanej badaniom sonograficznym (n = 263). Średnia wieku wynosiła 35,5 lat (zakres 20–64 lat).
Mediana stężenia jodu w moczu wynosiła 19.4 µg/dl. Obecność zmian ogniskowych tarczycy wykazano w badaniu sonograficznym
u 22,4% osób z badanej grupy; u 30% kobiet i 16,3% mężczyzn (OR = 2,2; p = 0,01). Częstość występowania zmian ogniskowych tarczycy
zwiększała się z wiekiem (p = 0,006). Zmiany ogniskowe tarczycy występowały częściej u osób z niedoczynnością tarczycy niż w grupie
z eutyreozą (35,1% v. 20,5%, OR = 2,1; p = 0,04). Nie stwierdzono korelacji między stężeniem jodu w moczu ani stężeniem autoprzeciw-
ciał a występowaniem zmian ogniskowych tarczycy w badaniu sonograficznym.
Wnioski: Częstość występowania zmian ogniskowych tarczycy oceniana na podstawie wyników badania sonograficznego jest nadal
duża w badanej populacji, mimo prawidłowego stężenia jodu w moczu. (Endokrynol Pol 2010; 61 (2): 188–191)
Słowa kluczowe: wole guzkowe, autoagresja, sonografia, jod, Iran
Introduction
Epidemiological data show that thyroid disorders such
as goiter, nodularity, and hyperthyroidism are more
common in areas of long-standing iodine deficiency.
After iodine supplementation, it is supposed that some
of these thyroid disorders should be decreased [1–7].
Ultrasonography is useful for several aspects of thy-
roid gland investigation, including measurement of size,
and finding nodularity and echogenicity [8, 9]. Although
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the majority of nodules are benign, the risk of malig-
nancy is about 1.5–10%, depending on ethnicity, age,
sex, and sonographic and clinical characteristics [10].
Iran used to be an iodine-deficient area before the
1990s; median urinary iodine before iodization was less
than 10 mg/dl in most regions of Iran. At that time, the
prevalence of nodular goiter had not been investigated
by sonography, although the goiter prevalence was high.
At that time, the national salt iodization program
(with 40 mg per one kilogram of salt) was initiated for
the general population [11, 12]. Despite a comprehen-
sive program, less than 50% of the households in rural
areas consumed iodized salt by 1994. Therefore, the
mandatory production of iodized salt for households
began in 1994. Seven years later, median urinary iodine
in school children was 20.5 µg/dL; 85.1% had urinary
iodine over 10 µg/dL. Median urinary iodine was more
than 13 µg/dL in all 26 provinces [11, 19].
After more than one decade of iodine supplemen-
tation, median urinary iodine excretion seems to be
within acceptable limits in our region, which indicates
an improved iodine supply [13].
The aim of the present study was to evaluate the cur-
rent status of sonographic and functional thyroid char-
acteristics in a subpopulation in Isfahan, a central city of
Iran, after 15 years of iodine supplementation in 2006.
Material and methods
This is a cross-sectional study, from January to April
2006, in Isfahan, an iodine-replete area of Iran, with
about two million inhabitants. A total of 2600 adult males
and females (age > 20 years) were invited to Isfahan
Endocrine and Metabolism Research Centre (IEMRC)
by means of random cluster sampling. Of the invited
people, 2523 (97%) persons accepted the invitation and
came to IEMRC for evaluation. Consent was obtained
from all participants. The Medical Ethics Committee of
Isfahan University of Medical Sciences approved the
study protocol which complied with the Helsinki Dec-
laration. Details of the main study have recently been
published [14].
Of these 2523 participants, 263 volunteered persons
underwent sonographic evaluation. Thyroid function
tests including TSH, T3, T4, and T3RU were carried out
in all subjects.
The normal range of serum TSH was 0.3–4 mIU/L,
serum T4 was 4.5–12 mg/dL, and serum T3 was 80–
–190 ng/dl. The normal range of T3RU was 25-35%.
Free T4 Index (fT4I) was calculated by T4 
x T3RU, Its
normal range was 1.3–4.8 mg/dL.
Thyroid status was defined as euthyroid when all
TSH, T4, T3, and FT4I levels were within the normal
range; Hypothyroidism, when TSH level was more than
4 mIU/L and T3 and/or T4 and/or fT4I was less than the
lower limit of the normal range; Subclinical hypothy-
roidism, when serum TSH was more than 4 mIU/L and,
T4, T3, and fT4I were within the normal range; Hyper-
thyroidism, when serum TSH level was less than the
lower limit of the normal range and T4 and/or T3 and/or
fT4I was above the normal range; Subclinical hyperthy-
roidism, when TSH level was less than 0.3 mIU/L and
normal T4, T3, fT4I.
Serum TPO Ab and Tg Ab levels were measured in
86 out of 263 people. Values of TPO Ab above 75 IU/L
and Tg Ab above 100 IU/L were considered positive.
Urinary iodine concentration was measured in 211 out
of 263 people. Iodine deficiency was defined as a median
of urinary iodine concentration of less than10 mg/dL.
Thyroid ultrasonography was performed with HS-2000
Honda Ultrasound equipment with 7.5 MHZ, Linear
probe. The subjects were examined in a supine posi-
tion with hyperextend neck, statistical analysis: As Anti
Tg, Anti TPO, TSH, and urinary iodine concentration
were not distributed normally, so they were reported
as median and compared between groups by Mann-
Whitney test. Normally distributed data were reported
as mean and standard deviation. We used the t-test to
compare the two groups. We used odds ratio (OR) and
95% confidence interval (CI) when appropriate, and we
used the Chi-square test to investigate the correlation
between qualitative variables.
Statistical analysis was carried out using SPSS soft-
ware, Version 13. P-values less than 0.05 were consid-
ered statistically significant.
Results
Of 263 people who underwent sonographic evaluation
of the thyroid, 54% were male, 46% were female, and
mean age was 38.5 (10.9) with the range 20 to 64 years.
Urinary iodine was measured in 211 out of 263 par-
ticipants at random. The median of their urinary iodine
was 19.4 mg/dL. It was 18 mg/dL in men and 22 mg/dL
in women, the difference was not statistically signifi-
cant. There was no difference between the urinary io-
dine excretions in different age groups.
The prevalence of thyroid nodules, by sonography,
in 263 people was 22.4%. Thirty persons (11.4%) had
one thyroid nodule and twenty-three (8.7%) had mult-
inodules. The prevalence of thyroid nodules on sonog-
raphy was 30% in women and 16.3% in men (OR = 2.2,
P = 0.01).
The prevalence of thyroid nodules was age-depen-
dent, as shown in Table I. There was no relationship
between the number of nodules and age.
According to sonographic data, 58.5% of nodules
were hypoechoic, 15.1% of nodules were hyperechoic,
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and 3.8% had calcification in sonography. There was
no difference in echogenicity of nodules or calcification
between men and women.
When we included thyroid function status, the fre-
quency of thyroid nodules increased with hypothyroid-
ism (P = 0.007) (Table II).
There was no difference between autoimmunity and
iodine status in persons with and without thyroid nod-
ules at sonography.
Serum TSH, T4, and T3 were measured in all 263 people.
Their thyroid function is shown in Table III. There was no
correlation between age and serum TSH concentration.
TPO Ab and Tg Ab levels were measured in 86 out
of 263 persons. Positive TPO Ab was observed in 30.6%
and 32.6% of men and women, respectively. Positive
Anti TgAb was gender-dependent. It was 11.1% in men
and 30.0% in women (OR = 3.43, P = 0.03). The distri-
bution of increased TPO Ab and Tg Ab was not age-
dependent.
Discussion
A sample of 2523 persons of the general population in
Isfahan, a central city in Iran, was investigated [14]. The
present study is a report of thyroid nodule prevalence
detected by ultrasonography in a subgroup of that large
studied population. Isfahan used to be iodine deficient
until the 1990s when dietary salt was supplemented
with iodine. The current intake of iodine in this city is
now sufficient [14, 15].
The prevalence of clinical and subclinical hypothy-
roidism was 6.5% and 6.9% in the studied subpopula-
tion, respectively. This is not consistent with some oth-
er studies [16]. Several studies have shown that au-
toimmune hypothyroidism is more prevalent in io-
dine-replete areas [17, 18]. Positive Tg Ab was more
prevalent in women, who had more thyroid nodules
than men. These data suggest that autoimmunity may
be the cause of thyroid disorders in this iodine suffi-
cient area, something which should be evaluated by
further studies.
The prevalence of thyroid nodules at 22.4% is consis-
tent with other reports of thyroid nodules in sonogra-
phy [19, 20]. However, thyroid incidentaloma (normal
in physical examination) was 13.2% in the Isfahani pop-
ulation [21]. Most of the nodules were not malignant,
but could pose a risk of malignancy later in life [22].
Thyroid nodules were more prevalent in older par-
ticipants. This suggests that, although iodine-deficien-
cy predisposes thyroid disorders including nodules,
supplementation with iodine did not diminish thyroid
nodules. Prospective studies have shown that iodine
supplementation does not decrease the incidence of
Table II. Thyroid status of Isfahan adult people with and
without nodules, who underwent sonography in Iran in 2006
Tabela II. Czynność tarczycy ze zmianami ogniskowymi i bez
u dorosłych mieszkańców Isfahanu (Iran) badanych sonogra-
ficznie w 2006 roku
Thyroid function With nodule Without nodule
[n (%)] [n (%)]
59 (22.6)  202 (77.4)
Euthyroid 44 (74.6)* 179 (88.6)
Subclinical hypothyroidism 6 (10.2)* 11 (5.4)
Clinical hypothyroidism 6 (10.2)* 12 (5.9)
Hyperthyroidism 2 (3.4)* 0 (0)
* P = 0.007
Table III. Prevalence of thyroid abnormalities in Isfahan
adult people who underwent sonography in Iran in 2006
Tabela III. Występowanie zaburzeń czynności tarczycy
w dorosłej populacji Isfahanu (Iran) badanych sonograficznie
w 2006 roku
Thyroid status Men Women P
n (%) n (%)
142 (54) 121 (46)
Euthyroid 128 (90.1) 97 (80.2) 0.02
Subclinical hypothyroidism 8 (5.6) 9 (7.4) 0.10
Clinical hypothyroidism 5 (3.5) 13 (10.7) 0.02
Subclinical hyperthyroidism 1 (0.7) 1 (0.8) 0.10
Clinical hyperthyroidism 0 (0.0) 1 (0.8) 0.10
Table I. Prevalence of thyroid nodules, according to age group,
in adult people who underwent sonography in Isfahan, Iran,
in 2006
Tabela I. Występowanie zmian ogniskowych tarczycy
w zależności od grupy wiekowej w dorosłej populacji Isfahanu
(Iran) badanej sonograficznie w 2006 roku
Age groups Thyroid nodule Total
(Years) in sonography
Yes No
No. (%) No. (%)
21–24 3 (5.1%) 28 (13.9%) 31 (11.9%)
25–29 6 (10.2%) 22 (10.9%) 28 (10.7%)
30–34 3 (5.1%) 25 (12.4%) 28 (10.7%)
35–39 3 (5.1%) 28 (13.9%) 31 (11.9%)
40–44 15 (25.4%) 37 (18.3%) 52 (19.9%)
45–49 9 (15.3%) 32 (15.8%) 41 (15.7%)
≥ 50 20 (33.9%) 30 (14.9%) 50 (19.2%)
P = 0.006
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thyroid nodules in some areas [10]. This could be the
result of anatomical changes made by long-standing
iodine deficiency which is not expected to be resolved
by iodine supplementation.
We do not have any data about the prevalence of
thyroid nodules by sonography in our region before
iodine-supplementation with which to compare with
this data. However, this study shows that with increas-
ing median urinary iodine, the prevalence of thyroid
nodules tends to decrease in the population, although
this was not statistically significant. This might indicate
a beneficial effect of iodization, which can decrease
nodules of the thyroid but cannot eradicate the nod-
ules. The role of some other factors, such as autoimmu-
nity, should also be considered regarding the aetiology
of nodular formation in the thyroid. However, our sam-
ple size was not large enough to show the relationship
between autoimmunity and thyroid nodules.
The limitation of our study did not compare the
prevalence of thyroid nodules by sonography before
and after iodine supplementation due to lack of data
before iodization and small sample size.
Conclusions
The prevalence of thyroid nodules by sonography is in
accordance with most iodine sufficient areas of the
world. However, there are other factors like autoimmu-
nity, genetics, and unknown causes. In future, all of the
factors relating to thyroid nodules should be evaluated
in our country with a bigger sample size, and prophy-
lactic parameters should be found regarding thyroid
nodule formation.
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